Expert Reviews in Molecular Medicine, 2021 · DOI: https://doi.org/10.1017/erm.2021.22 · Published: November 1, 2021
The central nervous system (CNS), consisting of the brain and spinal cord, regulates the mind and functions of the organs. CNS diseases, leading to changes in neurological functions in corresponding sites and causing long-term disability, represent one of the major public health issues with significant clinical and economic burdens worldwide. Decellularised extracellular matrix (dECM)-based biomaterials have been recently utilised for CNS applications, closely mimicking the native tissue. dECM retains tissue-specific components, including proteoglycan as well as structural and functional proteins. This review focuses on the physical, chemical and biological methods for decellularisation of brain and spinal cord ECM in the context of CNS applications and specifically discusses innovative applications.
dECM biomaterials closely mimic native tissue and stimulate repair mechanisms associated with CNS damages, potentially improving treatment outcomes.
dECM scaffolds support sustained ex vivo growth of cells and promote axonal regeneration at lesion sites, facilitating tissue engineering applications.
The combination of dECM hydrogels with 3D printing technology can expedite the development of therapeutic solutions for neuronal diseases and injuries.